Top Markets
#1 PulseChain PulseChain +45.01%
#2 SkyAI SkyAI +14.51%
#3 Pump.fun Pump.fun +10.70%
#4 Unit Pump Unit Pump +10.70%
#5 Meteora Meteora +9.22%
#6 Glidr Glidr +8.75%
#7 OPENLOOT OPENLOOT +8.70%
#8 eCash eCash +8.55%
#9 Fake World Assets Fake World Assets +8.16%
#10 Verus Coin Verus Coin +7.75%
Coin of the day
PulseChain PulseChain
Settings
Language
ENGLISH
Currency
USD
Theme
Enzo Biochem, Inc. Enzo Biochem, Inc.

Enzo Biochem, Inc.

ENZ
Rank in Stocks #28164
Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics,... Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics, clinical laboratory services, and life sciences. The company's core activities involve the entire process of researching, developing, manufacturing, and commercializing diagnostic and scientific investigation products, drawing upon advancements in genetic engineering, biotechnology, and molecular biology. Its operations are organized into three primary segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products division is responsible for creating, producing, and distributing vital tools and reagents tailored for customers in clinical research, pharmaceutical development, and broader bioscience research. Its extensive product catalog features items such as proteins, antibodies, peptides, small molecules, labeling agents, dyes, and various kits. These offerings provide life science researchers with the means for target identification and validation, content analysis, gene expression studies, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also supplies specialized solutions to scientific experts investigating critical health areas, including cancer, cardiovascular ailments, neurological disorders, metabolic conditions (like diabetes and obesity), endocrine imbalances, infectious and autoimmune diseases, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment delivers a comprehensive spectrum of molecular and other clinical laboratory tests and procedures. These are utilized by physicians in routine patient care to help confirm or establish diagnoses, monitor the effectiveness of treatments or medications, and identify previously undiagnosed medical conditions. This division operates a central, full-service clinical laboratory in Farmingdale, New York, complemented by a network of 30 patient service centers across New York and New Jersey. Additionally, it runs dedicated "STAT" or rapid-response laboratories in New York City and Connecticut, alongside a full-service phlebotomy facility and an internal logistics department. The Therapeutics segment is dedicated to pioneering novel treatment approaches within the fields of gastrointestinal, infectious, ophthalmic, and metabolic diseases. Enzo Biochem distributes its array of products and services through its dedicated internal sales team and an extensive network of distributors, reaching both domestic and international markets. The company was established in 1976 and has its corporate headquarters situated in New York, New York.
Share Price
$0.5495
Last synced: 2025-05-15
Market Cap
$28.14M
Change (1 day)
4.70%
Change (1 year)
0.00%
Country
US
Trade Enzo Biochem, Inc. (ENZ)

Category

Healthcare
Earnings for Enzo Biochem, Inc. (ENZ)
Earnings in Apr 2025 TTM: $-7.84M
According to Enzo Biochem, Inc. latest financial reports the company's current earnings are $-7.84M. In 2023 the company made an earning of $-25.02M, a decrease compared to its 2022 earnings that were of $-18.26M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Enzo Biochem, Inc. from 2000 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $-7.84M -20.13%
2024 $-9.82M -60.77%
2023 $-25.02M 37.02%
2022 $-18.26M -331.89%
2021 $7.88M -127.61%
2020 $-28.52M -1,245.84%
2019 $2.49M -121.80%
2018 $-11.42M 371.43%
2017 $-2.42M -105.21%
2016 $46.52M -2,129.45%
2015 $-2.29M -76.86%
2014 $-9.91M -47.73%
2013 $-18.95M -53.69%
2012 $-40.92M 219.12%
2011 $-12.82M -42.40%
2010 $-22.26M -5.18%
2009 $-23.48M 115.54%
2008 $-10.89M -17.33%
2007 $-13.18M -22.54%
2006 $-17.01M -426.01%
2005 $5.22M -147.09%
2004 $-11.08M -293.52%
2003 $5.73M -44.63%
2002 $10.34M -15.46%
2001 $12.23M 59.50%
2000 $7.67M 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
$7.61B -97,141.19%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
$4.76B -60,832.05%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
- -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
$-252.70M 3,122.82%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
$1.42B -18,266.29%
US